Related by context. All words. (Click for frequent words.) 71 suicidal behavior 69 suicidal ideation 68 suicidal thoughts 68 psychotic symptoms 63 SSRIs 62 depressive disorders 62 suicidal behaviors 61 somatic symptoms 61 psychotic disorders 61 ADHD 61 fluoxetine Prozac 61 neuroleptic 61 major depressive disorder 61 depressive symptoms 61 paroxetine 61 hypomanic symptoms 61 atypical antipsychotic medications 61 nonadherence 60 antidepressant 60 Major Depressive Disorder 60 psychiatric disorders 60 schizophrenia 60 tardive dyskinesia 60 akathisia 60 bipolar depression 60 conventional antipsychotics 60 pediatric bipolar disorder 60 psychiatric comorbidities 60 SSRI antidepressant 60 suicidal tendencies 59 neuropsychiatric symptoms 59 depressive symptomatology 59 SSRI 59 antidepressants 59 ADHD medications 59 tricyclic antidepressants 59 psychiatric comorbidity 59 subclinical hypothyroidism 59 anxiety disorders 59 suicide ideation 58 ADHD symptoms 58 extrapyramidal symptoms 58 antidepressant medications 58 venlafaxine Effexor 58 Suicidal ideation 58 Prozac fluoxetine 58 paroxetine sertraline 58 dysthymia 58 antipsychotics 58 subclinical atherosclerosis 58 internalizing disorders 58 clozapine 58 comorbid 58 psychopathology 58 paroxetine Paxil 57 citalopram 57 acamprosate 57 EFFEXOR XR 57 SSRI antidepressants 57 mood disorders 57 stimulant medications 57 valproate 57 Abilify aripiprazole 57 risperidone Risperdal 57 supine hypertension 57 emotional lability 57 cholinergic tone 57 Suicidal thoughts 57 venlafaxine XR 57 atypicals 57 comorbid depression 57 psychosis 57 alexithymia 57 suicide attempters 57 serum folate concentrations 57 externalizing disorders 57 antiepileptic drugs 57 ziprasidone 57 NATRECOR R 57 atherothrombotic disease 57 antidepressant efficacy 57 antidepressant drugs 56 hyperactivity inattention 56 selective serotonin reuptake inhibitor 56 psychiatric morbidity 56 Selective Serotonin Reuptake Inhibitor 56 antidepressant medication 56 citalopram Celexa 56 depressive episodes 56 hyperkalemia 56 tiagabine 56 Paxil paroxetine 56 aripiprazole 56 schizoaffective disorder 56 nortriptyline 56 SRBD 56 generalized anxiety disorder GAD 56 prolactin levels 56 atypical antipsychotics 56 cerebral microbleeds 56 isotretinoin 56 antiepileptic drug 56 psychotic illness 56 montelukast 56 asthma exacerbations 56 anxiolytic 56 agitation irritability 56 euthymic 56 cardiovascular ischemic 56 periprocedural MI 56 RLAI 56 Celebrex celecoxib 56 vitamin D inadequacy 56 oxcarbazepine 56 SSRI prescriptions 56 ziconotide 56 antipsychotic 56 divalproex 56 psychosocial variables 55 poststroke depression 55 Antidepressant 55 depressive disorder 55 prescribing antidepressants 55 atypical antipsychotic 55 reboxetine 55 comorbid anxiety 55 suicidal ideations 55 symptom severity 55 PRISTIQ 55 generation antipsychotics 55 CONCERTA ® 55 anticholinergic effects 55 prodromal symptoms 55 attention-deficit/hyperactivity disorder ADHD 55 affective disorders 55 serotonin reuptake inhibitors 55 Depressive symptoms 55 polypharmacy 55 psychotic illnesses 55 elevated depressive symptoms 55 affective psychoses 55 SSRI SNRI 55 MERLIN TIMI 55 tricyclics 55 untreated psychosis 55 autistic traits 55 Lu AA# 55 migraineurs 55 subclinical cardiovascular disease 55 thromboembolism 55 bipolar disorder 55 pharmacologic treatments 55 Nocturia 55 depression 55 #HT#A partial agonist 55 menstrual migraine 55 affective psychosis 55 divalproex sodium 55 escitalopram Lexapro 55 thrombotic events 55 STEP BD 55 carotid IMT 55 depressive symptom 55 physiological arousal 54 hyperarousal 54 serum BDNF 54 androgen deficiency 54 premenstrual syndrome PMS 54 venous thromboembolism 54 comorbid disorders 54 Suicidality 54 generalized anxiety disorder 54 neurocognitive deficits 54 depression suicidal thoughts 54 antipsychotic efficacy 54 Paxil 54 cardiovascular morbidity 54 nondepressed 54 tricyclic antidepressant 54 hippocampal volume 54 desvenlafaxine succinate 54 bipolar illness 54 intensive statin therapy 54 hypochondriasis 54 haloperidol Haldol 54 atypical femur fractures 54 induced akathisia 54 cognitive impairment 54 opioid overdose 54 mood suicidal ideation 54 antidepressant therapy 54 quetiapine Seroquel 54 newer antipsychotics 54 impulsivity 54 tremors anxiousness depression 54 premenstrual dysphoric disorder 54 syncopal 54 Lp PLA2 54 psychotropic medications 54 INVEGA ® 54 sertraline Zoloft 54 clomipramine 54 atherothrombotic 54 psychopharmacological 54 olanzapine 54 posttraumatic stress disorder PTSD 54 myopathy rhabdomyolysis 54 serious neuropsychiatric symptoms 54 rofecoxib 54 mania hypomania 54 risperidone 54 hypomania 54 atherothrombotic events 54 neurocognitive functioning 53 nicotine dependence 53 bipolar disorders 53 Symbyax 53 Excessive daytime sleepiness 53 cardiac toxicity 53 lipid lowering medications 53 parasomnias 53 antipsychotic drugs 53 borderline personality disorder 53 psychopharmacologic 53 prodrome 53 abdominal adiposity 53 homicidal ideation 53 neuroleptics 53 amisulpride 53 upper gastrointestinal bleeding 53 antipsychotic medications 53 somatoform disorders 53 cardiovascular mortality 53 chlamydial infection 53 serum cholesterol 53 Clinical Psychiatry 53 torsades de pointes 53 euthymic patients 53 FROVA 53 statistically nonsignificant 53 Zoloft sertraline 53 asymptomatic PAD 53 Effexor venlafaxine 53 dissociative symptoms 53 SNRI 53 SSRIs selective serotonin 53 mental disorders 53 ranolazine 53 comorbid psychiatric disorders 53 unipolar depression 53 Chantix 53 antenatal depression 53 antidepressive 53 TEAEs 53 orthostatic hypotension 53 placebo controlled trials 53 antihypertensive therapy 53 atypical antipsychotic drugs 53 platelet reactivity 53 Selective serotonin reuptake inhibitors 53 opioid dependent 53 prescribed opioids 53 CVD mortality 53 T2DM 53 comorbid conditions 53 KIF6 carriers 53 psychological distress 53 selective serotonin reuptake inhibitors 53 RLS symptoms 53 severe hypoglycemia 53 schizophrenia schizoaffective disorder 53 cognitive dysfunction 53 baseline HbA1c 53 selective serotonin 53 recurrent ischemia 53 sedatives hypnotics 53 Selective Serotonin Re 53 psychodynamic psychotherapy 53 impaired cognition 53 rosiglitazone 53 lamotrigine 53 serotonin deficiency 53 microalbuminuria 53 dyslipidaemia 53 psychopathological symptoms 53 comorbidity 53 unmeasured confounders 53 depression suicidality 53 elevated CRP 53 nonfasting triglycerides 52 cardio metabolic 52 desvenlafaxine 52 QT interval prolongation 52 SSRI anti depressants 52 manic hypomanic 52 fluoxetine 52 Cognitive impairment 52 posttraumatic stress 52 APTIVUS r 52 rosiglitazone Avandia 52 recurrent VTE 52 TMS Therapy 52 Pathological gambling 52 paroxetine Seroxat 52 neuropsychiatric adverse 52 thromboembolic events 52 thromboembolic 52 clozapine Clozaril 52 pregabalin 52 Cognitive behavioral therapy 52 postoperative AF 52 aldosterone antagonists 52 NIHSS score 52 tryptophan depletion 52 GH deficiency 52 prodromal 52 cortisol secretion 52 Antipsychotic 52 Major depressive disorder 52 postmenopausal breast cancer 52 pharmacologic therapies 52 Focalin XR 52 definite stent thrombosis 52 vasomotor symptoms 52 Suicidal behavior 52 quetiapine 52 antiarrhythmic drug 52 neuroleptic drugs 52 venlafaxine 52 Comorbid 52 Prehypertension 52 uncontrolled asthma 52 opioid misuse 52 Paroxetine 52 schizotypal traits 52 obsessive compulsive disorder OCD 52 puerperal psychosis 52 albuminuria 52 QTc 52 Duloxetine 52 pharmacologic interventions 52 CLBP 52 LABAs 52 anticipatory anxiety 52 behavioral disturbances 52 elevated homocysteine 52 ACCORD Lipid 52 psychiatric diagnoses 52 CONCERTA 52 QT prolongation 52 chronicity 52 attention-deficit/hyperactivity disorder 52 myocardial infarctions MIs 52 COPD exacerbations 52 macrovascular disease 52 psychotropic medication 52 bulimia nervosa 52 SAPHRIS 52 testosterone supplementation 52 lipid abnormalities 52 Anxiety disorders 52 abnormal lipid 52 Erythropoietic therapies may 52 tricyclic antidepressants TCAs 52 neurocognitive impairment 52 antidepressant prescriptions 52 recurrent venous thromboembolism 52 HPA axis 52 psychopathic traits 52 salivary cortisol 52 cardiometabolic risk 52 subclinical hyperthyroidism 52 hepatotoxicity 52 psychotic episodes 52 imply causality 52 depressive illness 52 folate intake 52 white matter hyperintensities 52 rufinamide 52 antidepressant prescribing 52 Cymbalta duloxetine 52 newer atypical antipsychotics 52 macrovascular 52 SNRIs 52 colorectal adenomas 52 PREZISTA r 52 emotional reactivity 52 syndromal 52 antithrombotic 52 postmarketing adverse 52 renal toxicity 52 stimulant medication 52 Seroxat 52 Observational studies 52 anti depressant medications 52 phenytoin 52 MDD 52 bosentan 52 Antidepressant medications 52 GlaxoSmithKline Plc Paxil 51 coadministration 51 convergent validity 51 hypercalcemia 51 folate deficiency 51 newer antidepressants 51 depressive illnesses 51 QTc interval 51 nefazodone 51 Chronic insomnia 51 prolonged QT interval 51 anticonvulsants 51 SSRI selective serotonin 51 SGAs 51 OSAHS 51 febrile seizure 51 LUTS 51 etiological 51 statin therapy 51 postmarketing surveillance 51 subsyndromal 51 bipolar mania trials 51 depressive episode 51 Quetiapine 51 neuroimaging studies 51 QTc prolongation 51 PTSD symptoms 51 acute gout flares 51 colorectal neoplasia 51 neurodevelopmental outcome 51 antiseizure drugs 51 depressive relapse 51 hypomanic episodes 51 Aripiprazole 51 serotonergic 51 syncope 51 perinatal depression 51 AUDs 51 sertraline 51 PDE 5i 51 preterm delivery 51 bicifadine 51 reflux symptoms 51 atherogenic dyslipidemia 51 unmeasured confounding 51 antioxidant supplementation 51 affective disorder 51 HRQoL 51 elevated LDL cholesterol 51 β blockers 51 non metastatic osteosarcoma 51 EXJADE 51 glucose abnormalities 51 acting beta agonists 51 epilepsy 51 guideline concordant 51 cardiotoxicity 51 exhaled nitric oxide 51 chronic noncancer pain 51 stimulant ADHD 51 serum calcium 51 HRQOL 51 prolactin elevation 51 schizophrenia CIAS 51 psychiatric hospitalization 51 dysphoric 51 prostate carcinogenesis 51 premorbid 51 paranoid ideation 51 MMSE scores 51 duloxetine Cymbalta 51 anticonvulsant medications 51 lacosamide 51 nocturnal enuresis 51 electroconvulsive therapy ECT 51 neurodevelopmental outcomes 51 VaD 51 neurocognition 51 attempters 51 duloxetine 51 generalized anxiety 51 leukotriene receptor antagonists 51 NSAID 51 beta blocker therapy 51 antithrombotic therapy 51 psychiatric disorder 51 Treatment emergent adverse 51 severe asthma exacerbations 51 HbA1c levels 51 Prozac Paxil Zoloft 51 dopaminergic therapy 51 PGTC seizures 51 donepezil 51 nonvertebral fractures 51 RISPERDAL ® 51 cognitive behavioral therapies 51 Venlafaxine 51 virological failure 51 renal impairment 51 Tardive dyskinesia 51 lipid lowering agents 51 Lamotrigine 51 Efexor 51 dopamine antagonists 51 opioids 51 antiepileptics 51 prescribing anti depressants 51 postoperative delirium 51 postmenopausal hormone therapy 51 psychobiological 51 reuptake inhibitors 51 gout flares 51 cognitive deficits 51 tibolone 51 catastrophizing 51 antidiabetic medication 51 cerivastatin 51 pimozide 51 Attention-Deficit/Hyperactivity Disorder 51 serum IGF 51 extrapyramidal symptoms EPS 51 underdiagnosis 51 SJS TEN 51 venous thrombosis 51 annualized relapse 51 Social Phobia 51 thrombophilia 51 intracerebral haemorrhage 51 juvenile idiopathic arthritis 51 antipsychotic medication 51 A1c levels 51 sleep disturbances 51 dysthymic disorder 51 HER2 overexpression 51 statin 51 overactive bladder symptoms 51 tHcy 51 tolvaptan 51 myocardial ischemia 51 airway responsiveness 50 nonpsychiatric 50 Zeldox 50 Cognitive therapy 50 EoE 50 BRCA carriers 50 cardiovascular disease CVD 50 perimenopausal women 50 thyrotropin levels 50 medication nonadherence 50 opioid 50 induce orthostatic hypotension 50 HeFH 50 escitalopram 50 Clozaril 50 NATRECOR ® 50 QTc intervals 50 serotonin reuptake inhibitors SSRIs 50 guanfacine 50 nociceptive pain 50 Relieve Depression 50 paricalcitol 50 nonvertebral fracture 50 confounding variables 50 solifenacin 50 lactic acidosis 50 neuroticism 50 postmenopausal estrogen 50 primidone 50 Nesiritide 50 glucose intolerance 50 Topiramate 50 comorbid psychiatric 50 atomoxetine 50 Paliperidone ER 50 Chronic ITP 50 suicidal impulses 50 cardiac abnormalities 50 intima media thickness 50 NAbs 50 posttraumatic stress disorder 50 serum sodium 50 morphometric vertebral fractures 50 PRADAXA 50 CYP#D# inhibitor 50 ATACAND 50 non pharmacological interventions 50 sotalol 50 Keppra R 50 ramelteon 50 mitochondrial toxicity 50 5 HTTLPR 50 teratogenic 50 cerebrovascular events 50 Major Depressive Disorder MDD 50 mild TBI 50 lipid parameters 50 pulmonary hypertension PH 50 Generalized Anxiety Disorder 50 Serdolect 50 oral antidiabetes drugs 50 QT interval 50 systolic hypertension 50 nonpsychotic 50 venous thromboembolic events 50 correlational 50 #q# deletion syndrome 50 Antidepressants 50 cardiovascular hospitalization 50 Alcohol Dependence 50 pioglitazone 50 dose oral contraceptives 50 meta regression 50 HAMD 50 asthma exacerbation 50 adenoma recurrence 50 efalizumab 50 TOPAMAX ® 50 microvascular complications 50 orofacial clefts 50 C reactive protein 50 mood dysregulation 50 ADHF 50 VIIBRYD 50 T1DM 50 mood lability 50 AA Amyloidosis 50 febrile convulsions 50 somatic complaints 50 HbA 1c 50 schizophreniform disorder 50 Hepatotoxicity 50 cardiac conduction 50 elevated creatinine 50 prescription opioid 50 sociodemographic characteristics 50 Intervention Effectiveness 50 SSRI citalopram 50 pharmacological interventions 50 Oppositional Defiant Disorder 50 arterial stiffness 50 medication adherence 50 overdiagnosis 50 Compulsive hoarding 50 placebo controlled studies 50 non affective psychosis 50 ziprasidone Geodon 50 mirtazapine 50 persistent pulmonary hypertension 50 serotonin syndrome 50 adolescents 50 Primary IGFD 50 serum estradiol 50 cardiorespiratory fitness 50 psychophysiological 50 macrovascular events 50 TZDs 50 Pfizer Geodon 50 calcium supplementation 50 abrupt discontinuation 50 thromboembolic disease 50 residual confounding 50 PDE 5i medications 50 interpersonal psychotherapy 50 postoperative mortality 50 APOE e4 50 nonfatal MI 50 Bipolar Mania 50 manic depressive illness 50 fasting glucose levels 50 Neuroticism 50 metabolic syndrome MetS 50 polydrug 50 glitazones 50 compulsive hoarding 50 serotonin norepinephrine reuptake inhibitor 50 serum cortisol 50 anxiolytics 50 autonomic dysfunction 50 neurocognitive function 50 MEVACOR 50 arterial thromboembolic events 50 glucocorticoid therapy 50 anticholinergic 50 decompensation 50 tricyclic anti depressants 50 statins cholesterol lowering 50 cardiovascular disease 50 Zyprexa olanzapine 50 atherosclerotic disease 50 REMINYL ® 50 SUDEP 50 serotonin reuptake inhibitor 50 SEROQUEL 50 elevated cortisol 50 Imovane 50 Serious adverse reactions 50 Olanzapine 50 Subgroup analyzes 50 prostate cancer CaP 50 serum uric acid 50 psychosocial functioning 50 habitual snoring 50 serotonin norepinephrine reuptake inhibitors 50 urinary symptoms 50 tic severity 50 SEROQUEL XR 49 Anticonvulsants 49 pioglitazone Actos 49 hyperprolactinemia 49 attention-deficit/hyperactivity 49 paliperidone 49 dopamine agonists 49 TOPAMAX 49 STRIDE PD 49 depression suicidal ideation 49 warfarin therapy 49 confounder 49 salmeterol HFA MDI 49 delusions hallucinations 49 recurrent wheezing 49 serotonin neurotransmission 49 ischemic cardiovascular 49 prodromal phase 49 virologic failure 49 utero exposure 49 olanzapine Zyprexa 49 disordered eating 49 imipramine 49 Risperidone 49 varenicline 49 serum retinol 49 metabolic syndrome 49 GnRH agonists 49 antihypertensive medications 49 metabolic abnormalities 49 hepatic toxicity 49 telcagepant 49 inhaled corticosteroid 49 fibrate 49 somatoform 49 Polypharmacy 49 HMG CoA reductase inhibitors 49 comorbid substance 49 MAO inhibitors 49 lipid levels 49 dietary calcium intake 49 clobazam 49 typical antipsychotics 49 Nardil 49 Psychotic symptoms 49 spontaneous preterm delivery 49 mIU L 49 comorbid ADHD 49 serum potassium 49 serotonin reuptake inhibition 49 cTnT levels 49 schizophrenics 49 LATUDA 49 Attention Deficit Hyperactive Disorder 49 plasma folate 49 Secondhand smoke exposure 49 Cortisol levels 49 anticonvulsant medication 49 dissociative disorders 49 dysglycemia 49 intravenous bisphosphonates 49 urate levels 49 bipolar affective disorder 49 VTE 49 Valdoxan 49 beta carotene supplementation 49 clinically insignificant 49 ARCOXIA 49 Schizophrenics 49 psychostimulants 49 placebo controlled clinical 49 aldosterone antagonist 49 mental illness 49 thromboembolic complications 49 rehospitalization 49 valproic acid 49 analgesic medications 49 acute coronary syndromes ACS 49 breast tenderness 49 schizophrenia bipolar 49 depressive mood 49 Exacerbations 49 VADT 49 schizotypal personality disorder 49 EEG abnormalities 49 hydroxychloroquine 49 plasma homocysteine 49 selective COX 2 49 nephrotoxicity 49 riociguat 49 MADRS score 49 Avandia Actos 49 metabolic parameters 49 colorectal adenoma 49 OAB symptoms 49 APOE genotype 49 Vilazodone 49 emotional dysregulation 49 rFVIIa 49 lumiracoxib 49 tiotropium 49 cognitive behavioral therapy 49 ACTOS 49 agomelatine 49 NNT = 49 COX 2s 49 hypersomnia 49 neurodevelopmental impairment 49 NSAIDs 49 tranylcypromine 49 myocardial infarction MI 49 adrenal suppression 49 Atypical antipsychotics 49 monoamine oxidase inhibitors 49 recurrent preterm birth 49 Longitudinal studies 49 muraglitazar 49 Multiple logistic regression 49 aldosterone antagonist therapy 49 intima media thickness IMT 49 Torsades de Pointes 49 urinary N telopeptide 49 psychotherapies 49 inhaled steroids 49 serum leptin 49 dysthymic 49 opioid induced 49 antidiabetic 49 cilostazol 49 extracellular dopamine 49 quetiapine risperidone 49 psychodynamic therapy 49 severe hypoglycemic 49 testosterone deficiency 49 oral anticoagulation 49 olanzapine quetiapine 49 narcolepsy cataplexy 49 microbleeds 49 tocilizumab 49 PTSD 49 QIDS SR 49 idiopathic Parkinson disease 49 NOMID 49 antiepileptic drugs AEDs 49 neuropsychiatric 49 fluvoxamine 49 shorter telomere length 49 juvenile idiopathic arthritis JIA 49 eC SSRS 49 cognitive functioning 49 BMI percentile 49 hypovitaminosis D 49 microscopic hematuria 49 Vimpat ® 49 QT intervals 49 acute manic 49 Conduct Disorder 49 jaw osteonecrosis 49 ictal 49 Personality disorders 49 monoamine oxidase inhibitor 49 venous thromboembolism VTE 49 antidepressant monotherapy 49 carotid stenosis 49 serum calcium levels 49 familial AF 49 serum bicarbonate 49 Sibutramine Cardiovascular Outcomes 49 extrapyramidal disorder 49 depression anxiety 49 hypertensives 49 urinary cortisol 49 tumor histology 49 salmeterol 49 non aspirin NSAIDs 49 glatiramer acetate 49 diabetic gastroparesis 49 aspirin therapy 49 antidiabetic drug 49 Risperdal risperidone 49 carotid intima media 49 mirtazapine Remeron 49 modifiable risk 49 Luvox Effexor 49 pramipexole 49 biochemical imbalance 49 Nuedexta 49 chromium picolinate supplementation 49 etoricoxib 49 symptomatic VTE 49 dutasteride 49 topiramate Topamax 49 elevated liver enzymes 49 mGluR2 49 statin medications 49 osteoporotic fracture 49 silent myocardial ischemia 49 parkinsonian symptoms 49 Chantix varenicline 49 Postnatal depression 49 INVEGA 49 symptomology 49 symptom exacerbation 49 daytime alertness 49 methodological limitations 49 bupropion 49 sedative hypnotic 49 hyperglycemia 49 pharmacokinetic interaction 49 Parkinsonian symptoms 49 serum urate 49 arterial thickening 49 attain statistical significance 49 canakinumab 49 carotid atherosclerosis 49 Methylphenidate 49 sideeffects 49 bi polar disorders 49 reuptake inhibitor 49 anaphylactic episodes 49 thrombotic complications 49 stent thrombosis 49 arterial thrombosis 49 uric acid levels 49 neuropsychiatric events 49 elevated triglycerides 49 Anti psychotics 49 antidiabetic drugs 49 antiepileptic 49 Personality traits 49 DVT PE 49 Tolvaptan 49 Kaplan Meier curve 49 syndromic 49 DMARD 49 MMRV vaccine 49 liver toxicity 49 teriflunomide 49 systolic BP 49 insulin glargine 49 uptake inhibitors SSRIs 49 elevated blood glucose 49 tonic clonic seizures 49 hypoglycaemia 49 Strattera 49 symptomatology 49 binge eating disorders 48 postnatal depression 48 SCr 48 CANCIDAS 48 myocardial infarctions 48 nonpharmacologic 48 Transcranial magnetic stimulation 48 oral diclofenac 48 abatacept 48 BANZEL 48 armodafinil 48 Comorbidity 48 episodic migraine 48 noncardiovascular mortality 48 genital arousal 48 cardiac troponin 48 internalizing behaviors 48 spontaneous preterm birth 48 prescribed antidepressants 48 mammographic density 48 adrenal insufficiency 48 Vimpat R 48 antidepressants fluoxetine 48 cotinine levels 48 vagal nerve stimulation 48 antidepressants SSRIs 48 PROVIGIL 48 dysfunctional voiding 48 antiepileptic medications 48 serum urate levels 48 bronchial hyperresponsiveness 48 coxibs 48 ventricular tachyarrhythmia 48 ABILIFY Injection 48 hyperglycaemia 48 thiazide diuretic 48 anhedonia 48 DPNP 48 monoamines 48 cardiac valvulopathy 48 hypotensive 48 pyridostigmine 48 Zoloft Paxil 48 nocturnal hypoglycemia 48 probands 48 YMRS 48 underlying pathophysiology 48 Interpersonal psychotherapy 48 NUCYNTA TM